$XRAY Income Statement | Understand Stock

$XRAY

$9.35 +$0.13 (1.41%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net sales
Cost of products sold
Gross profit
Selling, general, and administrative expenses
Research and development expenses
Goodwill impairment
Restructuring and other costs
Intangible asset impairment and other costs
Goodwill and intangible asset impairments
Restructuring costs
Operating loss
Other income and expenses:
Interest expense, net
Other (income) expense, net
Loss before income taxes
Provision (benefit) for income taxes
Net loss
Less: Net loss attributable to noncontrolling interests
Net loss attributable to Dentsply Sirona
Net (loss) per common share attributable to Dentsply Sirona:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average common shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments